Could vitamin d levels predict nerve damage in diabetes?

NCT ID NCT07236723

Not yet recruiting Knowledge-focused Sponsor: Aswan University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will measure vitamin D and nerve growth factor levels in 57 men with type 2 diabetes and nerve damage, comparing them to diabetic men without nerve damage and healthy men. Researchers will also test nerve function using electrical studies. The goal is to see if low vitamin D or nerve growth factor is linked to worse nerve damage, which could guide future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could point toward vitamin D or nerve growth factor as targets for future treatments for diabetic neuropathy.
What could go wrong: This is a small observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to women or other groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic neuropathy hereditary sensory and autonomic neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC NEUROPATHY

Contacts and locations

Locations

Aswan university hospital

Aswān, Aswan Governorate, 81157, Egypt
Aswan university hospital

Aswān, Aswan Governorate, Aswan, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.